m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell- mediated rejection

Journal of Experimental Medicine

Volumn 190, Issue 3, 1999, Pages 435-443

  Cretney, Erika ^a   Degli Esposti, Mariapia A ^b   Densley, Eloise H ^b   Farrell, Helen E ^c   Davis Poynter, Nick J ^c   Smyth, Mark J ^a,d  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c Centre for Preventative Medicine   (United Kingdom)

^d NONE   (Australia)

Author keywords

Cytomegalovirus; Cytotoxicity; Mouse; Natural killer cells; Tumour immunity

Indexed keywords

INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CANCER CELL CULTURE; CYTOMEGALOVIRUS; CYTOTOXICITY; HUMAN; HUMAN CELL; LYMPHOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR RESISTANCE; VIRUS INFECTION;

EID: 0033517104     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.3.435     Document Type: Article

References (31)

1. Scalzo, A.A., N.A. Fitzgerald, C.R. Wallace, A.C. Gibbons, Y.C. Smart, R.C. Burton, and G.R. Shellam. 1992. The effect of cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149:581-589.
2. Orange, J.S., and Biron, C.A. 1996. An absolute and restricted requirement for 1L-12 in natural killer cells IFN-γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1138-1142.
3. Orange J.S., B.P. Wang, C. Terhorst, and C.A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045-1056.
4. Biron, C.A. 1997. Activation and function of natural killer cell responses during viral infection. Curr. Opin. Immunol. 9:24-34.
5. Britt, W.J., and C.A. Alford. 1996. Cytomegalovirus. In Fields of Virology. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman, and S.E. Straus, editors. Lippincott-Raven Publishers, Philadelphia. 2493-2523.
6. Campbell, A.E., J.S. Slater, V.J. Cavanaugh, and R.M. Sternberg. 1992. An early event in murine cytomegalovirus replication inhibits presentation of cellular antigens to cytotoxic T lymphocytes. J. Virol. 66:3011-3017.
7. del Val, M., H. Hengel, H. Hacker, U. Hertlamb, T. Ruppert, P. Lucin, and U.H. Koszinowski. 1992. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med. 176: 729-738.
8. Rawlinson, W.D., H.E. Farrell, and B.G. Barrell. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849.
9. Fahnestock, M.L., J.L. Johnson, R.M.R. Feldman, J.M. Neveu, W.S. Lane, and P.J. Bjorkman. 1995. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity. 3:583-590.
10. Chapman, T.L., and P.J. Bjorkman. 1998. Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J. Virol. 72:460-466.
11. Farrell, H.E., H. Vally, D.M. Lynch, P. Fleming, G.R. Shellam, A.A. Scalzo, and N.J. Davis-Poynter. 1997. Inhibition of natural killer cells by cytomegalovirus MHC class I homologue in vivo. Nature. 386:510-514.
12. Reyburn, H.T., O. Mandelboim, M. Valez-Gomez, D.M. Davis, L. Pazmany, and J.L. Strominger. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature. 386:514-519.
13. Braud, V.M., D.S.J. Allan, C.A. O'Callaghan, K. Soderstrom, A. D'Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, J.H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Science. 391:795-799.
14. Borrego, F., M. Ulbrecht, E.H. Weiss, J.E. Coligan, and A.G. Brooks. 1998. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexes with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer-mediated lysis. J. Exp. Med. 187:813-818.
15. Rajagopalan, S., and E.O. Long. 1999. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189:1093-1100.
16. Chang, C.S., L. Brossay, M. Kronenberg, and K.P. Kane. 1999. The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis. J. Exp. Med. 189: 483-491.
17. Kubota, A., S. Kubota, H.E. Farrell, N. Davis-Poynter, and F. Takei. 1999. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cell. Immunol. 191: 145-151.
18. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:31-37.
19. Smyth, M.J., V.R. Sutton, M.H. Kershaw, and J.A. Trapani. 1996. Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways. Transplantation. 62:1529-1532.
20. + cytotoxic T lymphocytes. J. Virol. 72:5948-5954.
21. Smyth, M.J., J.M. Kelly, A.G. Baxter, H. Korner, and J.D. Sedgwick. 1998. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J. Exp. Med. 188:1611-1619.
22. van den Broek, M.F., D. Kagi, R.M. Zinkernagel, and H. Hengartner. 1995. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25:3514-3516.
23. Ljunggren, H.G., and K. Karre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162:1745-1759.
24. Salazar-Mather, T.P., J.S. Orange, and C.A. Biron. 1998. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 187:1-14.
25. Leong, C.C., T.L. Chapman, P.J. Bjorkman, D. Formankova, E.S. Mocarski, J.H. Phillips, and L.L. Lanier. 1998. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 187:1681-1687.
26. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 7:273-282.
27. Grage-Griebenow, E., D. Lorenzen, R. Fetting, H.D. Flad, and M. Ernst. 1993. Phenotypical and functional characterization of Fc γ receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur. J. Immunol. 23:3126-3135.
28. Hosken, N.A., and M. Bevan. 1992. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S. J. Exp. Med. 175:719-729.
29. b binds conserved class I leader peptides derived from several mammalian species. J. Exp. Med. 188:973-978.
30. b molecule binds to a large subpopulation of murine NK cells. Eur. J. Immunol. 28:4356-4361.
31. Tay, C.H., and R.M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:267-275.